Meeting
2020 Genitourinary Cancers Symposium
Stereotactic body radiotherapy boost toxicity for high and intermediate-risk prostate cancer: Report of a multi-institutional study.
Authors
Irving D. Kaplan
Beth Israel Deaconess Medical Center, Boston, MA
Irving D. Kaplan , Limor Appelbaum , Nima Aghdam , Jarad Martin , Mark Sidhom , David Pryor , Joseph A. Aronovitz , Anand Mahadevan , Kevin F. Kennedy , Sean P. Collins
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers
Track
Urothelial Carcinoma,Adrenal Cancer,Penile Cancer,Prostate Cancer - Advanced,Prostate Cancer - Localized,Testicular Cancer,Urethral Cancer
Sub Track
Symptoms, Toxicities, and Whole-Person Care
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 365)
Abstract #
365
Poster Bd #
C17
Abstract Disclosures